FDA 483 - Stanford Blood Center - November 26, 2024
FDA 483 for Stanford Blood Center on November 26, 2024. Product: biologics. Access full analysis and detailed observations.
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
FDA 483 for Stanford Blood Center on November 26, 2024. Product: biologics. Access full analysis and detailed observations.
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Company
Stanford Blood CenterInspection Date
November 26, 2024
Product Type
biologics
People
ID: 3d98ce42-150d-4892-8aa9-1d84af2d5ac4
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox